Senior insider sale
Chief Financial Officer at SPYRE THERAPEUTICS, INC. — senior position signals high conviction
$3.10M
42.50K shares
What this filing means
BURROWS SCOTT L plans to sell 42.50K shares of SPYRE THERAPEUTICS, INC. valued at approximately $3.10M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/25/2026ACC: 0001950047-26-006485
Officer· Chief Financial Officer
Since Mar 2026
42.50K
Shares to sell
$3.10M
Approx. market value
15K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
6/25/2026
15KTotal acquired15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/25/2026 | Stock Option Exercise Cash | 15K | — |
| Total | 15K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
7.50K
Market value
$532.9K
6/1/2026
—Completed
Units to sell
12.50K
Market value
$892.2K
5/1/2026
—Completed
Units to sell
7.50K
Market value
$370.1K
4/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
15K
Market value
$1.31M
6/25/2026
Total
Units
42.50K
Value
$3.10M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/1/2026 | 7.50K | $532.9K | — | Completed |
5/1/2026 | 12.50K | $892.2K | — | Completed |
4/1/2026 | 7.50K | $370.1K | — | Completed |
| Planned — Approximate Date | ||||
6/25/2026 | 15K | $1.31M | NASDAQ | Planned |
| Total | 42.50K | $3.10M | ||